Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Karuna Therapeutics Inc | 225,688 | 225,688 | 0 | $38.16M | $71.43M | 44.49% | +$33.27M |
| Illumina, Inc.(ILMN) | 119,196 | 119,196 | 0 | $16.36M | $16.60M | 10.34% | +$233.6K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 368,665 | 368,665 | 0 | $12.08M | $11.91M | 7.42% | -$173.3K |
| Oculis Holding AG(OCS) | 606,684 | 518,933 | -87,751 | $6.67M | $5.83M | 3.63% | -$845.9K |
| Exscientia PlcADS | 859,892 | 859,892 | 0 | $3.89M | $5.51M | 3.43% | +$1.63M |
| Alpine Immune Sciences Inc | 182,280 | 263,940 | +81,660 | $2.09M | $5.03M | 3.13% | +$2.94M |
| Xenon Pharmaceuticals Inc.(XENE) | 106,680 | 106,680 | 0 | $3.64M | $4.91M | 3.06% | +$1.27M |
| Somalogic IncCL A | 1,696,558 | 1,696,558 | 0 | $4.05M | $4.29M | 2.67% | +$237.5K |
| Merus N V | 137,038 | 137,038 | 0 | $3.23M | $3.77M | 2.35% | +$537.2K |
| Kalvista Pharmaceuticals Inc | 234,573 | 304,277 | +69,704 | $2.26M | $3.73M | 2.32% | +$1.47M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 96,100 | +96,100 | $0 | $2.84M | 1.77% | +$2.84M |
| Pacific Biosciences of California, Inc.(PACB) | 136,655 | 274,488 | +137,833 | $1.14M | $2.69M | 1.68% | +$1.55M |
| BeOne Medicines AGADR(ONC) | 12,022 | 12,022 | 0 | $2.16M | $2.17M | 1.35% | +$5.9K |
| Incyte Corporation(INCY) | 32,022 | 32,022 | 0 | $1.85M | $2.01M | 1.25% | +$160.8K |
| Geron Corporation(GERN) | 753,550 | 913,550 | +160,000 | $1.60M | $1.93M | 1.20% | +$330.1K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 40,070 | 40,070 | 0 | $918.6K | $1.84M | 1.15% | +$923.4K |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 493,584 | 493,584 | 0 | $1.07M | $1.64M | 1.02% | +$565.2K |
| Replimune Group, Inc.(REPL) | 184,739 | 184,739 | 0 | $3.16M | $1.56M | 0.97% | -$1.60M |
| Exelixis, Inc.(EXEL) | 64,200 | 64,200 | 0 | $1.40M | $1.54M | 0.96% | +$137.4K |
| Bolt Biotherapeutics Inc | 1,166,952 | 1,166,952 | 0 | $1.21M | $1.31M | 0.81% | +$93.4K |
| Aerovate Therapeutics Inc | 47,936 | 47,936 | 0 | $650.5K | $1.08M | 0.68% | +$434.3K |
| Cabaletta Bio, Inc.(CABA) | 47,150 | 47,150 | 0 | $717.6K | $1.07M | 0.67% | +$352.7K |
| Acadia Pharmaceuticals Inc | 29,984 | 29,984 | 0 | $624.9K | $938.8K | 0.58% | +$313.9K |
| Entrada Therapeutics, Inc.(TRDA) | 49,082 | 49,082 | 0 | $775.5K | $740.6K | 0.46% | -$34.8K |
| ALX Oncology Holdings Inc.(ALXO) | 41,950 | 41,950 | 0 | $201.4K | $624.6K | 0.39% | +$423.3K |
| Biomea Fusion, Inc.(BMEA) | 40,000 | 40,000 | 0 | $550.4K | $580.8K | 0.36% | +$30.4K |
| argenx SEADR(ARGX) | 1,430 | 1,430 | 0 | $703.0K | $544.0K | 0.34% | -$159.0K |
| Athira Pharma Inc | 180,000 | 180,000 | 0 | $363.6K | $437.4K | 0.27% | +$73.8K |
| Eargo Inc | 147,904 | 147,904 | 0 | $321.1K | $383.1K | 0.24% | +$62.0K |
| Dbv Technologies S AADR | 370,950 | 370,950 | 0 | $504.5K | $353.4K | 0.22% | -$151.1K |
| BioMarin Pharmaceutical Inc.(BMRN) | 3,615 | 3,615 | 0 | $319.9K | $348.6K | 0.22% | +$28.7K |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 1,182 | +1,182 | $0 | $273.5K | 0.17% | +$273.5K |
| Affimed N V | 372,472 | 372,472 | 0 | $178.0K | $232.8K | 0.14% | +$54.8K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 17,847 | 17,847 | 0 | $126.4K | $106.9K | 0.07% | -$19.5K |
| Galera Therapeutics Inc | 613,223 | 613,223 | 0 | $107.4K | $89.2K | 0.06% | -$18.2K |
| AbCellera Biologics Inc.(ABCL) | 12,521 | 12,521 | 0 | $57.6K | $71.5K | 0.04% | +$13.9K |
| Kodiak Sciences Inc.(KOD) | 19,622 | 19,622 | 0 | $35.3K | $59.7K | 0.04% | +$24.3K |
| Fibrogen Inc | 62,106 | 62,106 | 0 | $53.6K | $55.0K | 0.03% | +$1.5K |
| Cerus Corporation(CERS) | 14,172 | 14,172 | 0 | $23.0K | $30.6K | 0.02% | +$7.7K |
| AKERO THERAPEUTICS INCCOM | 4,425 | 0 | -4,425 | $223.8K | $0 | — | -$223.8K |
| SEAGEN INCCOM | 47,096 | 0 | -47,096 | $9.99M | $0 | — | -$9.99M |